Longeveron LGVN
NASDAQ LGVN
$0.84 +0.02 (+2.02%)
At close: Aug 21, 2026 · 4:00 PM EDT

Longeveron (LGVN) Cash & Equivalents (2021 - 2026)

Longeveron (LGVN) posted quarterly Cash & Equivalents of $15.8 million for Q1 2026, up 9.99% year-over-year from $14.3 million in Q1 2025, and up 238.08% quarter-over-quarter from $4.7 million in Q4 2025.

Longeveron (LGVN) Cash & Equivalents (2021 - 2026) Analysis & Trends

Longeveron's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $15.8 million for Q1 2026.

  • In Q1 2026, Cash & Equivalents rose 9.99% year-over-year to $15.8 million; the TTM figure through Mar 2026 stood at $15.8 million (up 9.99% YoY), while the FY2025 annual figure was $4.7 million, down 75.76% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $15.8 million, up from $4.7 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $22.8 million in Q3 2024, with the low at $1.9 million in Q1 2023.
  • The 5-year median for Cash & Equivalents is $9.8 million (2025), against an average of $9.5 million.
  • The sharpest annual moves came in 2024 and 2025: Cash & Equivalents jumped 1058.01% in 2024, then slumped 75.76% in 2025.
  • Longeveron's Cash & Equivalents stood at $10.5 million in 2022, then plunged by 52.88% to $4.9 million in 2023, then surged by 288.6% to $19.2 million in 2024, then plunged by 75.76% to $4.7 million in 2025, then surged by 238.08% to $15.8 million in 2026.
  • Business Quant data shows LGVN's Cash & Equivalents at $15.8 million in Q1 2026, $4.7 million in Q4 2025, and $9.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.72 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.71 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.93 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 544.80 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 811.99 Mn
10 Longeveron 26.51 Mn 16.41 Mn 182,000.00 10.10 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 10.10 Mn
Mar 31, 2026 15.76 Mn
Dec 31, 2025 4.66 Mn
Sep 30, 2025 9.24 Mn
Jun 30, 2025 10.30 Mn
Mar 31, 2025 14.33 Mn
Dec 31, 2024 19.23 Mn
Sep 30, 2024 22.78 Mn
Jun 30, 2024 12.40 Mn
Mar 31, 2024 1.94 Mn
Dec 31, 2023 4.95 Mn
Sep 30, 2023 1.97 Mn
Jun 30, 2023 2.75 Mn
Mar 31, 2023 1.90 Mn
Dec 31, 2022 10.50 Mn
Dec 31, 2021 25.66 Mn